CHICAGO, ILLINOIS--(Marketwired - May 20, 2013) - Bio-Solutions Corporation (OTCBB:BISU)(PINKSHEETS:BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal involving their diabetic product, Type-2 Defense, which is a preventative supplement for people who are diabetic or who are pre-diabetic. This product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant.
Bio-Solutions and Mark Block, who is head of the Jay Cutler Foundation, have been involved in preliminary talks concerning the endorsement deal for the past 4 weeks with outside consultants who were brought in by Bio-Solutions. They brought in outside consultants whose sole purpose was to find the best suitable athletes to endorse their Type-2 Defense product and carry their company's mission while representing their vision.
Bio-Solutions recognizes Jay Cutler as the best possible candidate because of his long-term battle with type-1 diabetes and his generosity in helping others who suffer from diabetes. Cutler, who established the Jay Cutler Foundation, raises money for diabetes research and to help children with type-1 diabetes.
Type-2 Defense samples are in the process of being shipped to Mark Block in Nashville, Tennessee where after received they will contact the National Football League to confirm that all the ingredients are compatible with the National Football Leagues' collective bargaining agreement. Bio-Solutions' Type-2 Defense samples should arrive to Block Agency in Nashville at the end of this week.
Jay Cutler will be looking over the Type-2 Defense product and the proposed endorsement deal over the next week and will make a decision on whether or not to take on this endorsement deal and team up with Bio-Solutions Corporation.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.